
Policy· June 10, 2026 · 8 min read
The 2026–2032 patent cliff by the numbers: 11,000 patents, $200 billion at risk
By Ran Chen#Orange Book#Generic Entry#Biosimilars
Patent/exclusivity records, therapeutic-equivalence codes, reference-listed drugs, and ANDA planning.




